An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Intratympanic Steroid Therapy as a Salvage Treatment for Sudden Sensorineural Hearing Loss
Fernandez et al. (2026) completed a retrospective analysis of 86 patients seen between 2019 and 2024 with sudden sensorineural hearing loss (SSNHL). This analysis compared…
Clinical Superiority of Belly-Tendon Montage Over Others for Recording Air-Conducted Ocular Vestibular Evoked Myogenic Potential
In a recent study published by Raveendran and Singh (2026), a number of ocular vestibular evoked myogenic potential (oVEMP) electrode montages were compared. This study…
Advocacy Continues to Protect Student Loan Access for Audiology Students
The public comment period on the Department of Education’s proposed changes to federal student loan regulations has now closed, but the Academy’s work to protect…


